Relay Therapeutics, Inc.: cashflow_investing
| Value | {"amount": 257634000, "concept": "us-gaap:NetCashProvidedByUsedInInvestingActivities", "currency": "USD"} |
|---|---|
| Period | 2023-01-01 – 2023-12-31 |
| Status | current |
| Entity | Relay Therapeutics, Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:14:39.378863+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/df3b6fd1-8ee9-42d8-882b-94a8c70e1bca
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-24-018797Retrieved: 2026-08-19T18:14:39.378863+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001812364/cashflow-investing/2023-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/df3b6fd1-8ee9-42d8-882b-94a8c70e1bca
History
- no predecessors — first report